title: Endothelial Dysfunction in Renal Interstitial Fibrosis.
abstract: Kidney disease affects millions of people worldwide and it is now widely accepted that many pathological processes may persist after acute kidney injury that can cause the progression to CKD. Tubulointerstitial fibrosis manifests soon after injury and while many cellular and molecular components of kidney fibrosis have been discovered, largely in animal models, new therapeutic strategies are still desperately needed. The renal endothelium has emerged as important in progression of fibrosis through regulation of hypoxia, inflammation and cellular crosstalk. This review aims to highlight our current understanding of the role of the endothelium in interstitial fibrosis and to identify potential therapeutic targets. © 2016 S. Karger AG, Basel.
authors: Division of Nephrology, Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia Health System, Charlottesville, Va., USA.
authors: Heather M
authors: HM
authors: Perry
authors: Mark D
authors: MD
authors: Okusa
mesh_terms: D004727:Endothelium / Q000503:physiopathology*; D005355:Fibrosis / Q000503:physiopathology; D006801:Humans; D007674:Kidney Diseases / Q000503:physiopathology*